Nanjing Medlander Medical Technology Co.,Ltd. engages in the research and development, manufacture, sale, and service of pelvic floor rehabilitation equipment and related products in China and internationally. It offers pelvic floor and obstetrics and gynecology rehabilitation, reproductive rehabilitation and anti-aging product, and sports rehabilitation products, as well as consumables and IT pro...
Nanjing Medlander Medical Technology reported revenue of 431.59 million CNY for fiscal year 2025, up 1.7% from fiscal year 2024, and net income of 102.63 million CNY. In Q1 2026 (the quarter ended March 31, 2026) revenue was 99.20 million CNY, down 16.1% from a year before. Its largest business segment, Pelvic Floor Rehabilitation, brought in 38% of segment revenue in fiscal year 2025; China was the largest region with 99%.
Figures from company filings; latest fiscal year ended December 31, 2025.
No profile data available.